Global Blood Transfusion Devices Market Overview:
Blood transfusion is a medical procedure that involves the transfusion of blood and blood components to the patients to replace the lost parts of the blood. The blood transfusion devices market is expected to grow in the future due to a high prevalence of blood-related disorders and rise in the incidence of chronic kidney disorders across the globe. Moreover, technological advancements in apheresis systems, infusion pumps, blood warmers, and transfusion filters have facilitated the availability of safe and highly purified blood to patients is boosting the market growth
- Increasing Number of Surgical Procedures
- Rise in the Number of Blood Disorders
- Technological Advancements in the Devices
- Stringent Regulatory Framework
- Increasing Infrastructure Developments in Developing Countries
- Rising Healthcare Expenditures
- High Costs Associated with the Device
The Blood Transfusion Devices market is highly competitive and consists of several major players. However, with technological advancements and product innovation, mid-size to smaller companies are increasing their market presence by introducing new products with cost-effective pricing.
Some of the key players profiled in the report are Macopharma SA (France), Becton Dickinson (United States), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), Abbott Laboratories (United States), Haemonetics Corporation (United States), Fresenius Kabi (Germany), Immucor Inc. (United States), Tenko Medical System Corp (United States), Grifols SA (Spain), Haemonetics Corporation (United States) and Armstrong Medical (United Kingdom). Analyst at AMA Research see United States Players to retain maximum share of Global Blood Transfusion Devices market by 2025. Considering Market by End User, the sub-segment i.e. Hospitals will boost the Blood Transfusion Devices market.
In May 2019, Ecomed Solutions has launched its HEMAsavR device for blood capture and transfer to help medical professionals reduce the costliness of allogeneic blood transfusions.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Blood Transfusion Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Blood Transfusion Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Blood Transfusion Devices Manufacturers, Blood Transfusion Devices Distributors/Traders/Wholesalers, Blood Transfusion Devices Subcomponent Manufacturers, Industry Association, Downstream Vendors, Medical Institutes, Government Regulatory Bodies, Government and Private Research Organizations and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.